Baldwin Insurance Group (BWIN) is on investors’ radar after a rebrand from BRP Group in May 2024. The company’s independent insurance distribution model and its mixed recent share performance over the past month and the past 3 months have drawn particular attention.
See our latest analysis for Baldwin Insurance Group.
At a share price of $20.12, Baldwin Insurance Group’s 30 day share price return is down 22.08%, while its 90 day share price return is up 21.72%. However, the 1 year total shareholder return has fallen 46.57%, indicating fading momentum after a recent rebound.
If this kind of move has you thinking about what else is out there, it could be a good moment to broaden your search with the 20 top founder-led companies
With the stock down 46.57% over the past year and trading at a discount of about 47% to the latest analyst price target, you have to ask: is there mispricing here, or is the market already factoring in future growth?
Most Popular Narrative: 31.4% Undervalued
At a last close of $20.12 versus a narrative fair value of about $29.33, the most followed view sees Baldwin Insurance Group trading at a sizeable discount, with that gap hinging on a specific set of growth and margin assumptions.
The analysts have a consensus price target of $29.33 for Baldwin Insurance Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $40.0, and the most bearish reporting a price target of just $23.0.
Want to see what justifies paying more than today’s price? The narrative leans on steady revenue expansion, a return to profitability, and a rich earnings multiple. Curious which specific forecasts and discount rate assumptions push fair value toward $30 and beyond? The full story sits inside that narrative model.
Result: Fair Value of $29.33 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors also need to weigh softer Mainstreet growth and elevated leverage, since pressure on Medicare commissions or tighter credit conditions could challenge this upbeat valuation story.
Find out about the key risks to this Baldwin Insurance Group narrative.
Next Steps
With sentiment in this article pulling in both cautious and optimistic directions, it makes sense to move quickly and test the numbers yourself, then weigh the 1 key reward and 2 important warning signs
Looking for more investment ideas?
If you stop with just one stock, you risk missing opportunities that could suit your goals better, so keep widening your universe with focused, data driven screens.
- Spot potential income anchors by reviewing 10 dividend fortresses, which can help keep your portfolio’s cash flow front and center.
- Hunt for quality at a discount with the 51 high quality undervalued stocks, which highlight companies trading below their assessed worth.
- Strengthen your core holdings by checking the solid balance sheet and fundamentals stocks screener (46 results), designed to surface businesses with financial foundations that may handle pressure more effectively.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com